Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 8, 2018
Patent Application Number
15116712
Date Filed
February 6, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to, inter alia, combinations, methods, compositions, and oral dosage forms of a FAK inhibitor and a MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
